Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
出版年份 2023 全文链接
标题
Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin
作者
关键词
-
出版物
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-08-26
DOI
10.1007/s10928-023-09877-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment
- (2022) Erika Ramsdale et al. ONCOLOGIST
- Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology
- (2021) Stephanie N. Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
- (2021) Hsuan Ping Chang et al. Journal of Clinical Medicine
- Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapy
- (2021) Zsolt Hepp et al. Future Oncology
- Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
- (2020) Mohamed Elmeliegy et al. CLINICAL PHARMACOKINETICS
- EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
- (2020) Jonathan Rosenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
- (2019) Jonathan E. Rosenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection
- (2018) Martin C. S. Wong et al. Scientific Reports
- Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
- (2016) P. M. Challita-Eid et al. CANCER RESEARCH
- Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro
- (2016) Guillaume Brachet et al. MOLECULAR PHARMACEUTICS
- Pharmacokinetics interactions of monoclonal antibodies
- (2016) Nicola Ferri et al. PHARMACOLOGICAL RESEARCH
- Hospitalizations Due to Adverse Drug Events in the Elderly—A Retrospective Register Study
- (2016) Outi Laatikainen et al. Frontiers in Pharmacology
- Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions
- (2015) R. W. F. van Leeuwen et al. ANNALS OF ONCOLOGY
- Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer
- (2015) Satoshi Nishiwada et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
- (2015) Stylianos Bournazos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bladder cancer in the elderly patient: challenges and solutions
- (2015) Chunkit Fung et al. Clinical Interventions in Aging
- Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates
- (2014) Yuan Chen et al. CLINICAL PHARMACOKINETICS
- CYP3A-Mediated Drug-Drug Interaction Potential and Excretion of Brentuximab Vedotin, an Antibody−Drug Conjugate, in Patients With CD30-Positive Hematologic Malignancies
- (2013) Tae H. Han et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates
- (2012) Mauro Acchione et al. mAbs
- Potentially Harmful Drug–Drug Interactions in the Elderly: A Review
- (2011) Lisa E. Hines et al. American Journal Geriatric Pharmacotherapy
- Mechanisms of Monoclonal Antibody–Drug Interactions
- (2011) Honghui Zhou et al. Annual Review of Pharmacology and Toxicology
- Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum
- (2010) Melissa S. DeRycke et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now